TransMedics Group, Inc. Interest Expense
TransMedics Group, Inc. (TMDX) reported Interest Expense of $3.62 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-01.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-08-01
- TransMedics Group, Inc. interest expense for the quarter ending 2024-06-30 was $3.62M, a 44.63% increase year-over-year.
- TransMedics Group, Inc. interest expense for the quarter ending 2024-03-31 was $3.60M, a 229.79% increase year-over-year.
- TransMedics Group, Inc. interest expense for the quarter ending 2023-12-31 was $3.60M, a 257.99% increase year-over-year.
- TransMedics Group, Inc. interest expense for the quarter ending 2023-09-30 was $3.59M, a 356.16% increase year-over-year.
- TransMedics Group, Inc. interest expense for fiscal 2023 was $10.79M, a 189.61% increase from fiscal 2022.
- TransMedics Group, Inc. interest expense for fiscal 2022 was $3.73M, a 3.82% decline from fiscal 2021.
- TransMedics Group, Inc. interest expense for fiscal 2021 was $3.87M, a 2.79% decline from fiscal 2020.
- TransMedics Group, Inc. interest expense for fiscal 2020 was $3.98M, a 8.45% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $3.62M 10-Q · filed 2024-08-01 | $7.22M 10-Q · filed 2024-08-01 | $10.83M derived: sum of 3 quarters · filed 2024-08-01 | $14.42M derived: sum of 4 quarters · filed 2024-08-01 |
| 2024-03-31 | $3.60M 10-Q · filed 2024-05-02 | $7.20M derived: sum of 2 quarters · filed 2024-05-02 | $10.79M derived: sum of 3 quarters · filed 2024-05-02 | $13.30M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $7.20M derived: sum of 2 quarters · filed 2024-02-27 | $9.70M derived: sum of 3 quarters · filed 2024-08-01 | $10.79M 10-K · filed 2024-02-27 |
| 2023-09-30 | $3.59M 10-Q · filed 2023-11-08 | $6.09M derived: sum of 2 quarters · filed 2024-08-01 | $7.19M 10-Q · filed 2023-11-08 | $8.19M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-06-30 | $2.50M 10-Q · filed 2024-08-01 | $3.60M 10-Q · filed 2024-08-01 | $4.60M derived: sum of 3 quarters · filed 2024-08-01 | $5.39M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $1.09M 10-Q · filed 2024-05-02 | $2.10M derived: sum of 2 quarters · filed 2024-05-02 | $2.88M derived: sum of 3 quarters · filed 2024-05-02 | $3.86M derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.79M derived: sum of 2 quarters · filed 2024-02-27 | $2.77M derived: sum of 3 quarters · filed 2024-02-27 | $3.73M 10-K · filed 2024-02-27 |
| 2022-09-30 | $787.00K 10-Q · filed 2023-11-08 | $1.76M derived: sum of 2 quarters · filed 2023-11-08 | $2.72M 10-Q · filed 2023-11-08 | $3.70M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $972.00K 10-Q · filed 2023-08-04 | $1.93M 10-Q · filed 2023-08-04 | $2.91M derived: sum of 3 quarters · filed 2024-02-27 | $3.89M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $960.00K 10-Q · filed 2023-05-04 | $1.94M derived: sum of 2 quarters · filed 2024-02-27 | $2.92M derived: sum of 3 quarters · filed 2024-02-27 | $3.88M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $978.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.96M derived: sum of 2 quarters · filed 2024-02-27 | $2.92M derived: sum of 3 quarters · filed 2024-02-27 | $3.87M 10-K · filed 2024-02-27 |
| 2021-09-30 | $979.00K 10-Q · filed 2022-11-04 | $1.94M derived: sum of 2 quarters · filed 2022-11-04 | $2.90M 10-Q · filed 2022-11-04 | $3.87M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $965.00K 10-Q · filed 2022-08-03 | $1.92M 10-Q · filed 2022-08-03 | $2.89M derived: sum of 3 quarters · filed 2023-02-27 | $3.86M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $952.00K 10-Q · filed 2022-05-05 | $1.92M derived: sum of 2 quarters · filed 2023-02-27 | $2.89M derived: sum of 3 quarters · filed 2023-02-27 | $3.90M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $971.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $1.94M derived: sum of 2 quarters · filed 2023-02-27 | $2.94M derived: sum of 3 quarters · filed 2023-02-27 | $3.98M 10-K · filed 2021-03-11 |
| 2020-09-30 | $971.00K 10-Q · filed 2021-11-09 | $1.97M derived: sum of 2 quarters · filed 2021-11-09 | $3.01M 10-Q · filed 2021-11-09 | $4.08M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $1.00M 10-Q · filed 2021-08-06 | $2.04M 10-Q · filed 2021-08-06 | $3.11M derived: sum of 3 quarters · filed 2021-08-06 | $4.19M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $1.04M 10-Q · filed 2021-05-07 | $2.10M derived: sum of 2 quarters · filed 2021-05-07 | $3.19M derived: sum of 3 quarters · filed 2021-05-07 | $4.30M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-28 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $2.15M derived: sum of 2 quarters · filed 2021-03-11 | $3.26M derived: sum of 3 quarters · filed 2021-03-11 | $4.35M 10-K · filed 2021-03-11 |
| 2019-09-28 | $1.08M 10-Q · filed 2020-11-06 | $2.20M derived: sum of 2 quarters · filed 2020-11-06 | $3.29M 10-Q · filed 2019-11-08 | |
| 2019-06-29 | $1.11M 10-Q · filed 2020-08-07 | $2.21M 10-Q · filed 2020-08-07 | ||
| 2019-03-30 | $1.09M 10-Q · filed 2020-05-06 | |||
| 2018-12-29 | $2.72M 10-K · filed 2020-03-17 | |||
| 2018-09-29 | $1.08M 10-Q · filed 2019-11-08 | $1.39M derived: sum of 2 quarters · filed 2019-11-08 | $1.65M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $313.00K 10-Q · filed 2019-08-08 | $571.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $258.00K 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |